Use of endothelial-leukocyte adhesion molecule-1 specific antibodies in the treatment of asthma
US5843441A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1995 |
| Grant date | Dec 1, 1998 |
| Priority date | — |
| Expiry date | Jul 19, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating asthma in a patient using an agent selected from the group consisting of: PA1 (a) an antibody capable of binding to ELAM-1; PA1 (b) a fragment of the antibody (a), the fragment being capable of binding to ELAM-1; PA1 (c) ELAM-1, being substantially free of natural contaminants; PA1 (d) a functional derivative of ELAM-1; PA1 (e) an antibody capable of binding to an ELAM-1 receptor; PA1 (f) a fragment of the antibody (e), the fragment being capable of binding to an ELAM-1 receptor; PA1 (g) an ELAM-1 receptor, being substantially free of natural contaminants; and . PA1 (h) a functional derivative of an ELAM-1 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.